Eagle Ridge Investment Management / ABT
Eagle Ridge Investment Management’s Abbott Laboratories Position
Does Eagle Ridge Investment Management own Abbott Laboratories (ABT)? Yes — 102.4K shares worth $12M (+1.01% of its 13F portfolio) as of Q4 2024, up from 102.0K shares the prior filed quarter.
Position Value
$12M
Q4 2024
Shares
102.4K
% of Portfolio
+1.01%
Quarters Held
25
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2024 | 102.4K | $12M | +1.01% |
| Q3 2024 | 102.0K | $12M | +1.02% |
| Q2 2024 | 101.8K | $11M | +0.98% |
| Q1 2024 | 103.1K | $12M | +1.08% |
| Q4 2023 | 103.7K | $11M | +1.12% |
| Q3 2023 | 103.9K | $10M | +1.10% |
| Q2 2023 | 104.7K | $11M | +1.20% |
| Q1 2023 | 104.4K | $11M | +1.19% |
| Q4 2022 | 104.9K | $12M | +1.34% |
| Q3 2022 | 106.2K | $10M | +1.29% |
| Q2 2022 | 105.8K | $11M | +1.38% |
| Q1 2022 | 104.5K | $12M | +1.32% |
| Q4 2021 | 104.8K | $15M | +1.54% |
| Q3 2021 | 108.9K | $13M | +1.43% |
| Q2 2021 | 107.5K | $12M | +1.45% |
| Q1 2021 | 109.7K | $13M | +1.59% |
| Q4 2020 | 141.5K | $15M | +1.96% |
| Q3 2020 | 146.8K | $16M | +2.23% |
| Q2 2020 | 147.6K | $13M | +2.04% |
| Q1 2020 | 159.0K | $13M | +2.18% |
| Q4 2019 | 170.2K | $15M | +1.98% |
| Q3 2019 | 170.8K | $14M | +2.07% |
| Q2 2019 | 175.1K | $15M | +2.14% |
| Q1 2019 | 177.1K | $14M | +2.08% |
| Q4 2018 | 178.1K | $13M | +2.19% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Eagle Ridge Investment Management’s full portfolio or all institutional holders of ABT.